Argent Trust Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.2M | Sell |
27,417
-215
| -0.8% | -$218K | 0.86% | 23 |
|
|
2025
Q4 | $29.7M | Sell |
27,632
-279
| -1% | -$267K | 1.02% | 19 |
|
|
2025
Q3 | $21.3M | Sell |
27,911
-242
| -0.9% | -$180K | 0.75% | 28 |
|
|
2025
Q2 | $21.9M | Buy |
28,153
+3,315
| +13% | +$2.58M | 0.83% | 28 |
|
|
2025
Q1 | $20.5M | Buy |
24,838
+303
| +1% | +$252K | 0.84% | 27 |
|
|
2024
Q4 | $18.9M | Buy |
24,535
+479
| +2% | +$397K | 0.77% | 27 |
|
|
2024
Q3 | $21.3M | Buy |
24,056
+709
| +3% | +$637K | 0.88% | 24 |
|
|
2024
Q2 | $21.1M | Sell |
23,347
-608
| -3% | -$486K | 0.93% | 22 |
|
|
2024
Q1 | $18.6M | Buy |
23,955
+997
| +4% | +$710K | 0.84% | 23 |
|
|
2023
Q4 | $13.4M | Buy |
22,958
+839
| +4% | +$490K | 0.67% | 35 |
|
|
2023
Q3 | $11.9M | Buy |
22,119
+367
| +2% | +$189K | 0.65% | 34 |
|
|
2023
Q2 | $10.2M | Buy |
21,752
+503
| +2% | +$211K | 0.55% | 43 |
|
|
2023
Q1 | $7.3M | Buy |
21,249
+2,536
| +14% | +$855K | 0.46% | 55 |
|
|
2022
Q4 | $6.85M | Buy |
18,713
+31
| +0.2% | +$11K | 0.45% | 62 |
|
|
2022
Q3 | $6.04M | Sell |
18,682
-985
| -5% | -$312K | 0.44% | 64 |
|
|
2022
Q2 | $6.38M | Buy |
19,667
+1,657
| +9% | +$497K | 0.44% | 62 |
|
|
2022
Q1 | $5.16M | Sell |
18,010
-560
| -3% | -$144K | 0.31% | 74 |
|
|
2021
Q4 | $5.13M | Buy |
18,570
+447
| +2% | +$113K | 0.3% | 77 |
|
|
2021
Q3 | $4.19M | Buy |
18,123
+154
| +0.9% | +$38K | 0.27% | 90 |
|
|
2021
Q2 | $4.13M | Buy |
17,969
+107
| +0.6% | +$21.5K | 0.27% | 91 |
|
|
2021
Q1 | $3.34M | Buy |
17,862
+967
| +6% | +$189K | 0.23% | 98 |
|
|
2020
Q4 | $2.85M | Buy |
16,895
+1,194
| +8% | +$178K | 0.22% | 101 |
|
|
2020
Q3 | $2.32M | Sell |
15,701
-326
| -2% | -$50.5K | 0.2% | 108 |
|
|
2020
Q2 | $2.63M | Buy |
16,027
+2,139
| +15% | +$328K | 0.25% | 94 |
|
|
2020
Q1 | $1.93M | Buy |
13,888
+1,538
| +12% | +$211K | 0.22% | 109 |
|
|
2019
Q4 | $1.62M | Buy |
12,350
+990
| +9% | +$115K | 0.14% | 148 |
|
|
2019
Q3 | $1.27M | Sell |
11,360
-7
| -0.1% | -$779 | 0.12% | 160 |
|
|
2019
Q2 | $1.26M | Buy |
11,367
+296
| +3% | +$34.9K | 0.13% | 160 |
|
|
2019
Q1 | $1.44M | Buy |
11,071
+3,404
| +44% | +$414K | 0.15% | 149 |
|
|
2018
Q4 | $887K | Sell |
7,667
-331
| -4% | -$37K | 0.1% | 190 |
|
|
2018
Q3 | $850K | Hold |
7,998
| – | – | 0.1% | 188 |
|
|
2018
Q2 | $682K | Buy |
7,998
+4,121
| +106% | +$338K | 0.08% | 214 |
|
|
2018
Q1 | $300K | Buy |
3,877
+507
| +15% | +$40.8K | 0.09% | 218 |
|
|
2017
Q4 | $285K | Sell |
3,370
-298
| -8% | -$25.4K | 0.11% | 202 |
|
|
2017
Q3 | $314K | Sell |
3,668
-41
| -1% | -$3.36K | 0.12% | 194 |
|
|
2017
Q2 | $305K | Sell |
3,709
-460
| -11% | -$37.5K | 0.13% | 205 |
|
|
2017
Q1 | $350K | Buy |
4,169
+10
| +0.2% | +$801 | 0.14% | 189 |
|
|
2016
Q4 | $306K | Sell |
4,159
-834
| -17% | -$62.1K | 0.14% | 195 |
|
|
2016
Q3 | $401K | Buy |
4,993
+809
| +19% | +$64.8K | 0.17% | 170 |
|
|
2016
Q2 | $329K | Buy |
4,184
+12
| +0.3% | +$903 | 0.14% | 186 |
|
|
2016
Q1 | $300K | Buy |
4,172
+269
| +7% | +$20.4K | 0.15% | 188 |
|
|
2015
Q4 | $329K | Buy |
3,903
+397
| +11% | +$32.9K | 0.16% | 171 |
|
|
2015
Q3 | $293K | Sell |
3,506
-650
| -16% | -$54.9K | 0.17% | 168 |
|
|
2015
Q2 | $347K | Buy |
4,156
+250
| +6% | +$19K | 0.17% | 168 |
|
|
2015
Q1 | $284K | Buy |
3,906
+389
| +11% | +$27.7K | 0.14% | 190 |
|
|
2014
Q4 | $243K | Buy |
+3,517
| New | +$237K | 0.15% | 182 |
|
Other funds holding LLY
VCM
VPM
Argent Trust Co's LLY Position: Q1 2026 in Review
Argent Trust Co reduced its Eli Lilly (LLY) stake by 0.78% in Q1 2026, selling an estimated $218K and leaving 27,417 shares worth $25.2M. The position accounts for 0.86% of the portfolio, ranked #23.
Argent Trust Co first reported a position in LLY in Q4 2014 and has held it in 46 quarters since. The position peaked at $29.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Argent Trust Co held 27,417 shares of Eli Lilly worth $25.2M as of Q1 2026.
- Argent Trust Co sold 215 Eli Lilly shares in Q1 2026, an estimated $218K.
- Eli Lilly made up 0.86% of Argent Trust Co's portfolio in Q1 2026, its #23 holding.
- Argent Trust Co first reported a position in Eli Lilly in Q4 2014 and has held it in 46 quarters since.
- Argent Trust Co's Eli Lilly position peaked at $29.7M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.